Our study aimed to examine immunohistochemical expression of CD105 in stage II rectal carcinomas and to investigate a correlation between CD105-assessed MVD and clinicopathological variables and to analyze prognostic value of MVD in the overall survival. This evidence concerns the gene ENG and rectal carcinoma.